To include your compound in the COVID-19 Resource Center, submit it here.

Titan starts CHF Phase IIb

TTP started a Phase IIb trial of its DITPA thyroid hormone analog to treat

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE